Novel Transport Mechanism For Large Ribonucleoproteins Has Implications For HerpesThe movement of genetic materials, such as RNA and ribosomes, from the nucleus to the cytoplasm is a critical component in a cell's ability to make the proteins necessary for essential biological functions. Until now, it was believed the nuclear pore complex was the sole pathway between the cell nucleus and cytoplasm for these materials...
Spinal Muscular Atrophy - Movement Defects Cause Possibly Found According to a study published in the April 11 issue of The Journal of Neuroscience, researchers have found that an abnormally low level of survival motor neuron protein (SMN), in certain nerve cells, is associated with mobility problems that characterize spinal muscular atrophy (SMA) - a deadly childhood disorder. SMA is a genetic disorder in which motor neurons do not produce enough SMN...
In Childhood Back Surgery, Risk Of Blood Loss Varies With Cause Of Spine DeformityThe relative risk of blood loss during corrective spine surgery in children appears linked to the underlying condition causing the spinal deformity, according to a new study from Johns Hopkins Children's Center. Results of the study, published online in the journal Spine, can help surgeons prepare, plan and safeguard against this common and serious complication, the investigators say...
Advances In Muscular Dystrophy Research Offer Treatment HopeAn international team led by the University of Melbourne Australia, has found that increasing a specific protein in muscles could help treat Duchenne muscular dystrophy (DMD), a severe and progressive muscle wasting disease that affects young boys. Approximately one in every 3,500 boys worldwide is afflicted with DMD...
Motor Neurone Disease Sees Stem Cell BreakthroughA breakthrough in a stem-cell programme funded by the UK-based MND Association has greatly improved the chances of developing effective treatments for Motor Neurone Disease (MND) of which the predominant form is Amyotrophic Lateral Sclerosis (ALS)...
Interim Results Of Neuralstem ALS Stem Cell TrialNeuralstem, Inc. (NYSE Amex: CUR) announced that safety results from the first 12 patients with amyotrophic lateral sclerosis (ALS or Lou Gehrig's disease) to receive its stem cells were reported online in the peer-reviewed publication, Stem Cell...
Widely Held View On Causal Mechanism In ALS Being QuestionedIn science, refuting a hypothesis can be as significant as proving one, all the more so in research aimed at elucidating how diseases proceed with a view toward preventing, treating, or curing them. Such a discovery can save scientists from spending precious years of effort exploring a dead end...